T. Mansourbakht

Nutritional Status Affects Treatment Tolerability and Survival in Metastatic Colorectal Cancer Patients: Results of an AGEO Prospective Multicenter Study

J. Sabate, F. Bonnetain, J. Taieb, 2012, Oncology.

FOLFIRI.3, a new regimen combining 5-fluorouracil, folinic acid and irinotecan, for advanced pancreatic cancer: results of an Association des Gastro-Enterologues Oncologues (Gastroenterologist Oncologist Association) multicenter phase II study.

J. Taïeb, J. Spano, J. Taieb, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study.

J. Taïeb, V. Boige, M. Hebbar, 2013, Journal of hepatology.

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC)

T. de Baère, M. Ducreux, J. Taïeb, 2007, Cancer.

Sarcopenia Is Linked to Treatment Toxicity in Patients With Metastatic Colorectal Cancer

Julien Taieb, Aziz Zaanan, J. Taieb, 2014, Nutrition and cancer.

Post-fracture osteolysis of the pubic bone simulating a malignancy: report of a case.

A. Saraux, J. Malhaire, P. Le Goff, 2004, Joint, bone, spine : revue du rhumatisme.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

P. Couzigou, M. Ducreux, C. Borel, 2018, European journal of cancer.

Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules

T. de Baère, M. Ducreux, J. Taïeb, 2003, Cancer.

Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: a large multicenter AGEO study.

J. Taïeb, V. Boige, M. Hebbar, 2013, Journal of hepatology.